AC Immune SA

AC Immune SA is a risky bet given it's low Altman Z-score. Companies with a low Altman Z-score have a higher chance of going bankrupt within the next 2 years. The momentum for this stock is not very good. AC Immune SA is not a good growth stock. AC Immune SA is a mediocre stock to choose.
Log in to see more information.
AC Immune SA is a clinical stage biopharmaceutical company, which engages in developing therapeutic...
ACIU Fundamental Data by TradingView

News

Banque Cantonale Vaudoise Decreases Position in AC Immune SA (NASDAQ:ACIU)
Banque Cantonale Vaudoise Decreases Position in AC Immune SA (NASDAQ:ACIU)

Ticker Report Banque Cantonale Vaudoise cut its holdings in AC Immune SA (NASDAQ:ACIU - Free Report) by 53.0% in the 2nd quarter, according to its most recent Form 13F filing with the Securities Exchange...\n more…

AC Immune SA (NASDAQ:ACIU) Short Interest Update
AC Immune SA (NASDAQ:ACIU) Short Interest Update

Zolmax AC Immune SA (NASDAQ:ACIU - Get Free Report) saw a large decrease in short interest during the month of August. As of August 15th, there was short interest totalling 784,000 shares, a decrease of...\n more…

AC Immune SA (NASDAQ:ACIU) Sees Significant Drop in Short Interest
AC Immune SA (NASDAQ:ACIU) Sees Significant Drop in Short Interest

Ticker Report AC Immune SA (NASDAQ:ACIU - Get Free Report) was the target of a large decrease in short interest in the month of August. As of August 15th, there was short interest totalling 784,000 shares, a...\n more…

FDA grants AC Immune's PI-2620 Tau-PET diagnostic fast track designations
FDA grants AC Immune's PI-2620 Tau-PET diagnostic fast track designations

The Fly See the rest of the story here.\n\nthefly.com provides the latest financial news as it breaks. Known as a leader in market intelligence, The Fly's real-time, streaming news feed keeps individual...\n more…

AC Immune's PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions
AC Immune's PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions

Globe Newswire AC Immune's PI-2620 Tau-PET Diagnostic in Phase 3 Receives Fast Track Designation in Three Neurodegenerative Conditions PI-2620 is in Phase 3 development in Alzheimer's disease by AC Immune's...\n more…

Assenagon Asset Management S.A. Has $1.76 Million Stock Holdings in AC Immune SA (NASDAQ:ACIU)
Assenagon Asset Management S.A. Has $1.76 Million Stock Holdings in AC Immune SA (NASDAQ:ACIU)

Ticker Report Assenagon Asset Management S.A. lifted its holdings in shares of AC Immune SA (NASDAQ:ACIU - Free Report) by 294.7% during the 2nd quarter, according to the company in its most recent 13F filing with...\n more…